<DOC>
	<DOCNO>NCT01539538</DOCNO>
	<brief_summary>The study intend show Sufentanil NanoTab PCA System effective morphine intravenous patient-controlled analgesia ( IV PCA ) treat pain surgery . Each patient use either Sufentanil NanoTab PCA System morphine IV PCA treat pain least 48 hour 72 hour surgery hospital .</brief_summary>
	<brief_title>A Multicenter , Randomized , Open-Label , Parallel-Group Trial Compare Efficacy Safety Sufentanil NanoTab PCA System/15 mcg ( Zalviso™ ) Intravenous Patient-Controlled Analgesia With Morphine Treatment Acute Post-Operative Pain</brief_title>
	<detailed_description />
	<mesh_term>Pain , Postoperative</mesh_term>
	<mesh_term>Morphine</mesh_term>
	<mesh_term>Sufentanil</mesh_term>
	<criteria>Male female patient 18 year old Patients schedule undergo open abdominal surgery ( include laparoscopicassisted ) , total knee total hip replacement surgery general anesthesia spinal anesthesia include intrathecal opioids operation . Postsurgical patient admit PACU expect remain hospitalized acute postoperative pain require parenteral opioids least 48 hour surgery . Patients take opioid 30 consecutive day , daily dose 15 mg morphine ( equivalent ) , within past 3 month prior surgery ( e.g . 3 dos per day Vicodin® , Norco® , Lortab® 5 mg hydrocodone per tablet ) . Patients allergy hypersensitivity opioids Female patient pregnant breastfeeding</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Adult post-operative inpatient</keyword>
	<keyword>expect require parenteral</keyword>
	<keyword>opioid analgesia least 48</keyword>
	<keyword>hour open abdominal surgery</keyword>
	<keyword>hip/knee replacement surgery</keyword>
</DOC>